Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Prostate cancer

Epidemiologic studies and changing clinical practice

A large Swedish population-based study has shown that 15-year prostate-cancer-related mortality rates are negligible for men with low-risk cancers treated noncuratively, but significant for those with intermediate-risk and high-risk tumours. Such data support current trends towards active surveillance for low-risk disease and aggressive multimodal treatment for advanced carcinomas.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Rider, J. R. et al. Long-term outcomes among noncuratively treated men according to prostate cancer risk category in a nationwide, population-based study. Eur. Urol. http://dx.doi.org/10.1016/j.eururo.2012.08.001.

  2. Abdollah, F. et al. Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort. Eur. Urol. 60, 920–930 (2011).

    Article  Google Scholar 

  3. Abdollah, F. et al. A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988–2006. Eur. Urol. 59, 88–95 (2011).

    Article  Google Scholar 

  4. Wilt, T. J. et al. Radical prostatectomy versus observation for localized prostate cancer. N. Engl. J. Med. 367, 203–213 (2012).

    Article  CAS  Google Scholar 

  5. Novara, G. et al. Systematic review and meta-analysis of perioperative outcomes and complications after robot-assisted radical prostatectomy. Eur. Urol. 62, 431–452 (2012).

    Article  Google Scholar 

  6. Ficarra, V. et al. Systematic review and meta-analysis of studies reporting potency rates after robot-assisted radical prostatectomy. Eur. Urol. 62, 418–430 (2012).

    Article  Google Scholar 

  7. Ficarra, V. et al. Systematic review and meta-analysis of studies reporting urinary continence recovery after robot-assisted radical prostatectomy. Eur. Urol. 62, 405–417 (2012).

    Article  Google Scholar 

  8. Mottet, N. et al. EAU guidelines on prostate cancer. Part II: Treatment of advanced, relapsing, and castration-resistant prostate cancer. Eur. Urol. 59, 572–583 (2011).

    Article  Google Scholar 

  9. Heidenreich, A. et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur. Urol. 59, 61–71 (2011).

    Article  Google Scholar 

  10. Briganti, A. et al. Combination of adjuvant hormonal and radiation therapy significantly prolongs survival of patients with pT2–4 pN+ prostate cancer: results of a matched analysis. Eur. Urol. 59, 832–840 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Vincenzo Ficarra.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Novara, G., Ficarra, V. Epidemiologic studies and changing clinical practice. Nat Rev Urol 9, 676–677 (2012). https://doi.org/10.1038/nrurol.2012.203

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrurol.2012.203

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing